Correlates of psychological intimate partner violence with HIV care outcomes on patients in HIV care

Among people living with HIV (PLWH), physical intimate partner violence (IPV) is associated with poor virologic, psychiatric, and behavioral outcomes. We examined non-physical, psychological intimate partner violence (psy-IPV) and HIV care outcomes using data from two U.S. consortia. We conducted mu...

Full description

Saved in:
Bibliographic Details
Published inBMC public health Vol. 21; no. 1; p. 1824
Main Authors Fredericksen, R J, Nance, R M, Whitney, B M, Harding, B N, Fitzsimmons, E, Del Rio, C, Eron, J, Feaster, D J, Kalokhe, A S, Mathews, W C, Mayer, K H, Metsch, L R, Mugavero, M J, Potter, J, O'Cleirigh, C, Napravnik, S, Rodriguez, B, Ruderman, S, Jac, Delaney, Crane, H M
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 09.10.2021
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Among people living with HIV (PLWH), physical intimate partner violence (IPV) is associated with poor virologic, psychiatric, and behavioral outcomes. We examined non-physical, psychological intimate partner violence (psy-IPV) and HIV care outcomes using data from two U.S. consortia. We conducted multivariable analyses with robust standard errors to compare patients indicating/not indicating psy-IPV. Among PLWH (n = 5950), 9.5% indicated psy-IPV; these individuals were younger (- 3; 95% CI [- 2,-4], p-value < 0.001), less likely to be on antiretroviral treatment (ART) (0.73 [0.55,0.97], p = 0.03), less adherent to ART (- 4.2 [- 5.9,-2.4], p < 0.001), had higher odds of detectable viral load (1.43 [1.15,1.78], p = 0.001) and depression (2.63 [2.18,3.18], p < 0.001), and greater use of methamphetamines/crystal [2.98 (2.30,3.87),p < 0.001], cocaine/crack [1.57 (1.24,1.99),p < 0.001], illicit opioids [1.56 (1.13,2.16),p = 0.007], and marijuana [1.40 (1.15,1.70), p < 0.001]. Psychological IPV, even in the absence of physical or sexual IPV, appears to be associated with HIV care outcomes and should be included in IPV measures integrated into routine HIV care.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1471-2458
1471-2458
DOI:10.1186/s12889-021-11854-x